Cargando…

The Effects of SIRT1 on Alzheimer's Disease Models

Sirtuins are highly conserved NAD(+)-dependent enzymes that were shown to have beneficial effects against age-related diseases. Aging is the major risk factor for all neurodegenerative disorders including Alzheimer's Disease (AD). Sirtuins have been widely studied in the context of AD using dif...

Descripción completa

Detalles Bibliográficos
Autor principal: Donmez, Gizem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518073/
https://www.ncbi.nlm.nih.gov/pubmed/23251824
http://dx.doi.org/10.1155/2012/509529
_version_ 1782252514222014464
author Donmez, Gizem
author_facet Donmez, Gizem
author_sort Donmez, Gizem
collection PubMed
description Sirtuins are highly conserved NAD(+)-dependent enzymes that were shown to have beneficial effects against age-related diseases. Aging is the major risk factor for all neurodegenerative disorders including Alzheimer's Disease (AD). Sirtuins have been widely studied in the context of AD using different mouse models. In most of these studies, overexpression of SIRT1 has been shown to have protective effects against AD. Therefore, designing therapeutics based on increasing SIRT1 activity might be important for investigating the ways of treatment for this disease. This paper summarizes the recent research on the effect of SIRT1 in AD animal models and also the potential of SIRT1 being a therapeutical target for AD.
format Online
Article
Text
id pubmed-3518073
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-35180732012-12-18 The Effects of SIRT1 on Alzheimer's Disease Models Donmez, Gizem Int J Alzheimers Dis Review Article Sirtuins are highly conserved NAD(+)-dependent enzymes that were shown to have beneficial effects against age-related diseases. Aging is the major risk factor for all neurodegenerative disorders including Alzheimer's Disease (AD). Sirtuins have been widely studied in the context of AD using different mouse models. In most of these studies, overexpression of SIRT1 has been shown to have protective effects against AD. Therefore, designing therapeutics based on increasing SIRT1 activity might be important for investigating the ways of treatment for this disease. This paper summarizes the recent research on the effect of SIRT1 in AD animal models and also the potential of SIRT1 being a therapeutical target for AD. Hindawi Publishing Corporation 2012 2012-12-03 /pmc/articles/PMC3518073/ /pubmed/23251824 http://dx.doi.org/10.1155/2012/509529 Text en Copyright © 2012 Gizem Donmez. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Donmez, Gizem
The Effects of SIRT1 on Alzheimer's Disease Models
title The Effects of SIRT1 on Alzheimer's Disease Models
title_full The Effects of SIRT1 on Alzheimer's Disease Models
title_fullStr The Effects of SIRT1 on Alzheimer's Disease Models
title_full_unstemmed The Effects of SIRT1 on Alzheimer's Disease Models
title_short The Effects of SIRT1 on Alzheimer's Disease Models
title_sort effects of sirt1 on alzheimer's disease models
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518073/
https://www.ncbi.nlm.nih.gov/pubmed/23251824
http://dx.doi.org/10.1155/2012/509529
work_keys_str_mv AT donmezgizem theeffectsofsirt1onalzheimersdiseasemodels
AT donmezgizem effectsofsirt1onalzheimersdiseasemodels